Previously published TCGA-based studies investigated STING expression in head and neck tumors at the transcriptomic level but did not discriminate between the impact of intrinsic tumor cell-specific STING signaling and cGAS–STING activation in immune cells. This evidence concerns the gene CGAS and neoplasm.